Hepatocellular carcinoma (HCC) is the most frequent liver cancer with high lethality and low
five-year survival rates leading to a substantial worldwide burden for healthcare systems …

Abstract This CIRSE Standards of Practice document is aimed at interventional radiologists
and provides best practices for performing transarterial chemoembolisation. It has been …

Standard for diagnosis and treatment of primary liver cancer (2022 edition) 中文|English ISSN
1001-5256 (Print) ISSN 2097-3497 (Online) CN 22-1108/R Home About Journal 1.Journal …

Background Current guidelines recommend surgical resection as the first-line option for
patients with solitary hepatocellular carcinoma (HCC); unfortunately, postoperative …

Immunotherapy is a promising approach to treating various types of cancers, including
hepatocellular carcinoma (HCC). While single immunotherapy drugs show limited …

Importance Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality,
and additional first-line treatments are needed. The programmed cell death protein 1 …

Advances in the surgical and systemic therapeutic landscape of hepatocellular carcinoma
have increased the complexity of patient management. A dynamic adaptation of the …

Hepatocellular carcinoma (HCC) is the second deadliest cancer worldwide, due to its high
incidence and poor prognosis. Frequent initial presentation at advanced stages along with …

Several breakthroughs in hepatocellular carcinoma (HCC) therapy across tumor stages
provide hope to improve its dismal prognosis. Although surgical and local ablative therapies …

Portal vein tumour thrombosis is common among patients with advanced hepatocellular
carcinoma. Tremendous differences exist in the management of hepatocellular carcinoma …